Mahendra Patel
Pediatric Hematology-Oncology · San Antonio, TXNPI 1194739342
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations.
Across 99 payments — averaging $23.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$295
- Novartis$285
- Mckesson Specialty Care Distribution, LLC$232
- Octapharma USA, Inc.$211
- Rigel Pharmaceuticals, Inc.$199
- Genetix Biotherapeutics Inc$185
- plus $902 from 15 others
What the payments were for
- Food & beverage$2,29199%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $295 |
| Novartis | 17 | $285 |
| Mckesson Specialty Care Distribution, LLC | 3 | $232 |
| Octapharma USA, Inc. | 10 | $211 |
| Rigel Pharmaceuticals, Inc. | 10 | $199 |
| Genetix Biotherapeutics Inc | 2 | $185 |
| CSL Behring | 9 | $176 |
| Pfizer | 7 | $160 |
| Pharming Healthcare, Inc. | 6 | $114 |
| Novo Nordisk | 4 | $86 |
| US Oncology Corporate, Inc. | 2 | $78 |
| Global Blood Therapeutics, Inc. | 3 | $74 |
| Sanofi | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Catalyst Pharmaceuticals, Inc. | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Apo-pharma USA, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Grifols USA, LLC | 1 | $16 |
| Fortovia Therapeutics, Inc. | 1 | $16 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zynteglo$172
How this compares
$2,309 in reported general payments places this provider in the 70th percentile of 235 pediatric hematology-oncology providers in Texas.
Other pediatric hematology-oncology in San Antonio
- Vinod Gidvani-DiazSan Antonio$101K
- Scott PenneySan Antonio$75K
- Chatchawin AssanasenSan Antonio$65K
- Samuel Pabon RiveraSan Antonio$23K
- Allison GrimesSan Antonio$21K
- Aaron SugalskiSan Antonio$9K
- Ghadir SasaSan Antonio$5K
- Lorimar RamirezSan Antonio$4K
- Mark GarciaSan Antonio$3K
- Anne-Marie LangevinSan Antonio$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.